CMMB — CHEMOMAB THERAPEUTICS LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 17 SEC-registered investment managers reported holding CMMB (CHEMOMAB THERAPEUTICS LTD) in their latest 13F filings, with a combined reported value of $490.17K across 405.40K shares. That is +13.3% by share count (+35.97K shares) versus the previous quarter, while reported value moved -16.7%. Ownership is concentrated: the five largest holders account for 71.3% of reported value and the top ten for 94.0%.
Compared with the prior quarter, 7 opened new positions, 5 added to existing stakes, 4 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CHEMOMAB THERAPEUTICS LTD (CMMB) include ORBIMED ADVISORS LLC, Yelin Lapidot Holdings Management Ltd., SPHERA FUNDS MANAGEMENT LTD., ranked by reported 13F value among the 40 institutional holders on this page.
CMMB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 17 | 405.40K | $490.17K | +13.3% |
| Q2 2026 | 13 | 379.83K | $615.33K | +13.0% |
| Q1 2026 | 15 | 351.56K | $551.95K | -7.5% |
| Q4 2025 | 14 | 367.38K | $606.13K | -43.6% |
| Q3 2025 | 10 | 390.31K | $1.03M | -86.4% |
| Q2 2025 | 14 | 4.23M | $4.91M | +15.2% |
| Q1 2025 | 16 | 3.73M | $4.07M | -10.8% |
| Q4 2024 | 15 | 4.16M | $7.53M | -8.0% |
Over the 8 quarters shown, institutional share counts decreased 90% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (-86.4%).
Top Institutional Holders (Q3 2026) — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 109.76K | $130.62K | 0.00% | Add | |
| 77.15K | $91.81K | 0.00% | Add | |
| 51.79K | $61.63K | 0.01% | Hold | |
| 30.07K | $35.78K | 0.00% | Reduce | |
| 18.62K | $29.81K | 0.00% | New | |
| 24.41K | $29.05K | 0.00% | New | |
| 22.57K | $26.85K | 0.02% | Add | |
| 19.64K | $23.37K | 0.00% | New | |
| 13.67K | $16.27K | 0.00% | New | |
| 13.03K | $15.51K | 0.01% | New | |
| 10.33K | $12.29K | 0.00% | New | |
| 9.18K | $10.93K | 0.00% | Add | |
| 3.30K | $3.93K | 0.00% | Reduce | |
| 1.60K | $1.90K | 0.00% | Reduce | |
| 235 | $378 | 0.00% | New | |
| 30 | $36 | 0.00% | Reduce | |
| 17 | $20 | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 95.31K | $154.40K | 0.00% | Add | |
| 80.00K | $129.60K | 0.01% | Hold | |
| 61.71K | $99.97K | 0.00% | Hold | |
| 51.79K | $83.90K | 0.01% | Hold | |
| 30.53K | $49.46K | 0.00% | Add | |
| 15.99K | $25.90K | 0.00% | Reduce | |
| 15.00K | $24.30K | 0.02% | Add | |
| 14.34K | $23.23K | 0.00% | New | |
| 6.80K | $11.02K | 0.00% | Reduce | |
| 4.74K | $7.68K | 0.00% | Reduce | |
| 3.58K | $5.79K | 0.00% | Reduce | |
| 34 | $55 | 0.00% | Add | |
| 8 | $13 | 0.00% | Hold |
Q1 2026 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 80.00K | $125.60K | 0.01% | Hold | |
| 64.18K | $100.77K | 0.00% | Reduce | |
| 61.71K | $96.89K | 0.00% | Add | |
| 51.79K | $81.31K | 0.01% | Hold | |
| 18.63K | $29.25K | 0.00% | Reduce | |
| 18.37K | $28.83K | 0.00% | Add | |
| 14.57K | $22.87K | 0.01% | New | |
| 13.49K | $21.18K | 0.00% | New | |
| 8.43K | $13.23K | 0.00% | Add | |
| 8.20K | $12.87K | 0.01% | New | |
| 7.58K | $11.90K | 0.00% | Add | |
| 4.58K | $7.18K | 0.00% | Add | |
| 28 | $44 | 0.00% | Add | |
| 8 | $13 | 0.00% | Reduce | |
| 8 | $13 | 0.00% | New |
Q4 2025 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 103.78K | $171.24K | 0.00% | New | |
| 80.00K | $132.00K | 0.01% | New | |
| 51.79K | $85.46K | 0.01% | Reduce | |
| 51.71K | $85.32K | 0.00% | New | |
| 19.01K | $31.37K | 0.00% | New | |
| 17.86K | $29.46K | 0.00% | Add | |
| 15.60K | $25.74K | 0.00% | Reduce | |
| 10.93K | $18.00K | 0.00% | New | |
| 8.12K | $13.41K | 0.00% | Add | |
| 3.77K | $6.23K | 0.00% | Reduce | |
| 2.51K | $4.15K | 0.00% | Add | |
| 2.25K | $3.72K | 0.00% | Add | |
| 26 | $43 | 0.00% | Hold | |
| 2 | $3 | 0.00% | New |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 179.43K | $471.89K | 0.11% | Reduce | |
| 90.06K | $236.87K | 0.00% | Reduce | |
| 53.26K | $140.08K | 0.02% | Reduce | |
| 30.00K | $78.90K | 0.06% | New | |
| 21.51K | $56.57K | 0.00% | Add | |
| 9.51K | $25.00K | 0.00% | Reduce | |
| 5.75K | $15.12K | 0.00% | Reduce | |
| 667 | $1.75K | 0.00% | Reduce | |
| 99 | $260 | 0.00% | Reduce | |
| 26 | $68 | 0.00% | Reduce |
Q2 2025 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.61M | $1.87M | 0.00% | Add | |
| 940.99K | $1.09M | 0.03% | Reduce | |
| 738.05K | $856.14K | 0.22% | Reduce | |
| 578.29K | $670.82K | 0.12% | Hold | |
| 213.05K | $247.14K | 0.08% | Hold | |
| 39.88K | $46.25K | 0.00% | Add | |
| 31.24K | $36.24K | 0.00% | Hold | |
| 26.19K | $30.38K | 0.00% | Hold | |
| 20.57K | $23.86K | 0.00% | New | |
| 13.90K | $16.12K | 0.00% | Add | |
| 12.81K | $14.86K | 0.00% | Add | |
| 1.18K | $1.37K | 0.00% | New | |
| 397 | $461 | 0.00% | Reduce | |
| 111 | $129 | 0.00% | Add |
New Positions (Q3 2026)
- StoneX Group Inc. 18.62K sh · $29.81K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 24.41K sh · $29.05K
- JANE STREET GROUP, LLC 19.64K sh · $23.37K
- TWO SIGMA SECURITIES, LLC 13.67K sh · $16.27K
- SmartHarvest Portfolios, LLC 13.03K sh · $15.51K
- Renaissance Technologies 10.33K sh · $12.29K
- Nuveen, LLC 235 sh · $378
Fully Exited (vs previous quarter)
- ADAR1 Capital Management, LLC sold 80.00K sh · $129.60K
- XTX Topco Ltd sold 15.99K sh · $25.90K
- Lido Advisors, LLC sold 14.34K sh · $23.23K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 109.76K | 95.31K | 64.18K | 103.78K | — | — | — | — | — | 62.40K | — | 32.68K | — | — | — | — | 21.23K | — | — | — |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 77.15K | 61.71K | 61.71K | 51.71K | — | 31.24K | 31.24K | 31.24K | 31.24K | 31.24K | 31.24K | 31.24K | 31.24K | — | — | — | — | — | — | — |
| Ikarian Capital, LLC | 51.79K | 51.79K | 51.79K | 51.79K | 53.26K | 213.05K | 213.05K | 213.05K | 213.39K | 213.39K | 213.39K | 213.39K | 213.39K | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 30.07K | 30.53K | 18.37K | 17.86K | 9.51K | 39.88K | 23.85K | 23.81K | 27.57K | 19.88K | 18.63K | 18.63K | 2.84K | — | — | — | — | — | — | — |
| StoneX Group Inc. | 18.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24.41K | — | 13.49K | — | — | — | — | — | — | — | 11.48K | — | — | — | — | — | — | — | — | — |
| Philadelphia Investment Partners, LLC | 22.57K | 15.00K | 8.20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 19.64K | — | — | 15.60K | 21.51K | 20.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | 13.67K | — | — | — | — | — | 22.10K | — | 39.94K | — | 26.18K | — | — | — | — | — | — | — | — | — |
| SmartHarvest Portfolios, LLC | 13.03K | — | 14.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 10.33K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 27.96K | — |
| GAMMA Investing LLC | 9.18K | 4.74K | 7.58K | 2.51K | 667 | 12.81K | 11.03K | 5.10K | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 3.30K | 6.80K | 8.43K | 8.12K | 5.75K | 13.90K | 10.50K | 6.50K | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.60K | 3.58K | 4.58K | 3.77K | 90.06K | 1.61M | 117.16K | 104.40K | 402.27K | 7.20K | 2.80K | 70.92K | — | 100 | 7.80K | 6.60K | 6.20K | 5.59K | — | 11.64K |
| Nuveen, LLC | 235 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 30 | 34 | 28 | 26 | 26 | 111 | 104 | 100 | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 17 | 8 | 8 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | — | — | — | — | — | 940.99K | 1.74M | 1.74M | 1.74M | 2.24M | 2.24M | 2.24M | 2.24M | — | — | — | — | — | — | — |
| SPHERA FUNDS MANAGEMENT LTD. | — | — | — | — | 179.43K | 738.05K | 900.43K | 1.21M | 1.21M | — | — | — | — | — | — | — | — | — | — | — |
| Yelin Lapidot Holdings Management Ltd. | — | — | — | — | — | 578.29K | 578.29K | 744.13K | 809.72K | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CMMB?
As of 2026-Q3, 17 institutional funds reported holding CMMB (CHEMOMAB THERAPEUTICS LTD) in SEC 13F filings, with a combined reported value of $490.17K.
How many shares of CMMB do institutions own?
13F filers reported 405.40K shares of CMMB, worth $490.17K in aggregate at the end of 2026-Q3.
Is institutional ownership of CMMB rising or falling?
Share counts moved +13.3% versus the prior quarter — accumulation.
Who are the top institutional holders of CMMB?
The largest 13F holders are ORBIMED ADVISORS LLC, Yelin Lapidot Holdings Management Ltd., SPHERA FUNDS MANAGEMENT LTD., Citadel Advisors, ADAR1 Capital Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of CHEMOMAB THERAPEUTICS LTD?
The major shareholders of CHEMOMAB THERAPEUTICS LTD (CMMB) by reported 13F value are ORBIMED ADVISORS LLC, Yelin Lapidot Holdings Management Ltd., SPHERA FUNDS MANAGEMENT LTD., Citadel Advisors, ADAR1 Capital Management, LLC, among 40 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.